NeuroMetrix Receives FDA 510(k) Clearance For UNIVERSAL(TM) Electrodes Used In The Performance Of Nerve Conduction Studies

NeuroMetrix, Inc. (Nasdaq: NURO) announced that it has received 510(k) clearance for its UNIVERSAL Electrodes from the U.S. Food and Drug Administration (FDA). This regulatory determination by the FDA gives NeuroMetrix clearance to market the UNIVERSAL Electrodes in the U.S. These electrodes are intended to be used with the NeuroMetrix ADVANCE(TM) NCS/EMG System for performance of nerve conduction studies.